| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|
OPERATING EXPENSES | |||||||||
Research and development | |||||||||
69,611 | 63,500 | 57,737 | 46,808 | 40,607 | 34,300 | 26,304 | 0 | 0 | 0 |
General and administrative | |||||||||
23,895 | 19,512 | 15,618 | 13,603 | 11,428 | 8,961 | 6,690 | 0 | 0 | 0 |
Total operating expenses | |||||||||
93,498 | 83,004 | 73,324 | 60,380 | 52,004 | 43,230 | 32,994 | 0 | 0 | 0 |
Loss from operations | |||||||||
-93,498 | -83,004 | -73,324 | -60,380 | -52,004 | -43,230 | -32,994 | 0 | 0 | 0 |
OTHER INCOME, NET | |||||||||
Interest and other income, net | |||||||||
2,225 | 1,976 | 1,372 | 924 | 279 | -44 | -47 | 0 | 0 | 0 |
NET LOSS | |||||||||
-91,273 | -81,028 | -71,952 | -59,456 | -51,725 | -43,274 | -33,041 | 0 | 0 | 0 |
Other comprehensive income | |||||||||
Foreign currency translation | |||||||||
12 | 43 | 179 | 84 | 228 | 175 | 67 | 0 | 0 | 0 |
COMPREHENSIVE LOSS | |||||||||
-91,261 | -80,985 | -71,773 | -59,372 | -51,497 | -43,099 | -32,974 | 0 | 0 | 0 |
Net loss per share attributable to common stockholders, basic and diluted | |||||||||
-0.66 | -0.60 | -0.70 | -0.53 | -0.47 | -0.41 | -0.42 | -0.39 | -0.28 | -0.21 |
Weighted average common shares outstanding, basic and diluted | |||||||||
39,753 | 37,974 | 34,371 | 34,193 | 34,193 | 34,259 | 27,330 | 26,749 | 26,749 | 17,945 |